Effectiveness of cold therapy on prevention of CIPN among patients receiving chemotherapy.
Phase 2
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/04/065873
- Lead Sponsor
- Sukhpal Kaur
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
i. Patients suffering from cancer undergoing chemotherapy for the first time with
neuro-toxic drugs.
ii. Patients willing to participate
iii. Above 18 years
Exclusion Criteria
i. Known case of Peripheral neuropathy(Diabeteic neuropathy, Raynaud’s
syndrome, carpal tunnel syndrome)
ii. Patients who are unable to report parasthesia and pain
iii. Patients undergoing palliative chemotherapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method These are the intensity of the symptoms – paraesthesia, burning, and pain that will be <br/ ><br>assessed using the NCI- CTCAE guidelines and EORTC CIPN-20 questionnaires. <br/ ><br> <br/ ><br>Timepoint: Outcome variables of the participants will be assessed at before administrating each chemotherapy cycle, and at after 30 minutes of each chemotherapy cycle. <br/ ><br>
- Secondary Outcome Measures
Name Time Method Quality of Life using EORTC-C30 toolTimepoint: At baseline, 3 months & at 6 months